# Haiyan Jing

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/haiyan-jing/

## Facts

| Field | Value |
| --- | --- |
| Citations | 726 |
| Field | Gastric Cancer Management and Outcomes |
| h-index | 14 |
| i10-index | 19 |
| Last Known Institution | Shandong Provincial Hospital |
| OpenAlex ID | https://openalex.org/A5051658832 |
| ORCID iD | 0000-0003-0913-6898 |
| Works | 51 |

## Researcher papers

- [Analysis of serum levels of 15 trace elements in breast cancer patients in Shandong, China](https://scholariq.org/papers/analysis-of-serum-levels-of-15-trace-elements-in-breast-cancer-patients-in/)
- [Immune Microenvironment Differences Between Squamous and Non-squamous Non–small-cell Lung Cancer and Their Influence on the Prognosis](https://scholariq.org/papers/immune-microenvironment-differences-between-squamous-and-non-squamous-non-small/)
- [SIRT1 Expression Is Associated with the Chemotherapy Response and Prognosis of Patients with Advanced NSCLC](https://scholariq.org/papers/sirt1-expression-is-associated-with-the-chemotherapy-response-and-prognosis-of/)
- [Apparent diffusion coefficients in prostate cancer: correlation with molecular markers Ki‐67, HIF‐1α and VEGF](https://scholariq.org/papers/apparent-diffusion-coefficients-in-prostate-cancer-correlation-with-molecular/)
- [Down-regulation of Intestinal Apical Calcium Entry Channel TRPV6 by Ubiquitin E3 Ligase Nedd4-2](https://scholariq.org/papers/down-regulation-of-intestinal-apical-calcium-entry-channel-trpv6-by-ubiquitin-e3/)
- [Suppression of intestinal calcium entry channel TRPV6 by OCRL, a lipid phosphatase associated with Lowe syndrome and Dent disease](https://scholariq.org/papers/suppression-of-intestinal-calcium-entry-channel-trpv6-by-ocrl-a-lipid/)
- [SULT1E1 inhibits cell proliferation and invasion by activating PPARγ in breast cancer](https://scholariq.org/papers/sult1e1-inhibits-cell-proliferation-and-invasion-by-activating-ppar-in-breast/)
- [Total neoadjuvant treatment with short-course radiotherapy followed by sintilimab plus capecitabine–oxaliplatin versus short-course radiotherapy followed by capecitabine–oxaliplatin in patients with locally advanced rectal cancer (SPRING-01): a single-centre, open-label, phase 2, randomised controlled trial](https://scholariq.org/papers/total-neoadjuvant-treatment-with-short-course-radiotherapy-followed-by/)
- [Prognostic role of tumour-infiltrating lymphocytes assessed by H&E-stained section in gastric cancer: a systematic review and meta-analysis](https://scholariq.org/papers/prognostic-role-of-tumour-infiltrating-lymphocytes-assessed-by-h-and-amp-e/)
- [Molecular characterization and clinical relevance of metabolic signature subtypes in gastric cancer](https://scholariq.org/papers/molecular-characterization-and-clinical-relevance-of-metabolic-signature/)
- [Histologic transformation of non-small-cell lung cancer in brain metastases](https://scholariq.org/papers/histologic-transformation-of-non-small-cell-lung-cancer-in-brain-metastases/)

## Researcher topics

- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Metastasis and carcinoma case studies](https://scholariq.org/topics/metastasis-and-carcinoma-case-studies/)
- [Gastrointestinal Tumor Research and Treatment](https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Researcher university

- [Shandong Provincial Hospital](https://scholariq.org/institutions/shandong-provincial-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.